ZA200604808B - Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents - Google Patents

Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents

Info

Publication number
ZA200604808B
ZA200604808B ZA200604808A ZA200604808A ZA200604808B ZA 200604808 B ZA200604808 B ZA 200604808B ZA 200604808 A ZA200604808 A ZA 200604808A ZA 200604808 A ZA200604808 A ZA 200604808A ZA 200604808 B ZA200604808 B ZA 200604808B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical agents
amine containing
containing pharmaceutical
liposome compositions
stable liposome
Prior art date
Application number
ZA200604808A
Other languages
English (en)
Inventor
Pliura Diana Helen
Ristevski Blagoja
Boylan James Charles
Li Hong
Original Assignee
Delex Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delex Therapeutics Inc filed Critical Delex Therapeutics Inc
Publication of ZA200604808B publication Critical patent/ZA200604808B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200604808A 2003-11-20 2006-06-12 Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents ZA200604808B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52331603P 2003-11-20 2003-11-20

Publications (1)

Publication Number Publication Date
ZA200604808B true ZA200604808B (en) 2007-11-28

Family

ID=34619598

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200604808A ZA200604808B (en) 2003-11-20 2006-06-12 Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents

Country Status (13)

Country Link
US (1) US20070269502A1 (no)
EP (1) EP1689364A4 (no)
JP (1) JP2007511545A (no)
KR (1) KR20060123341A (no)
CN (2) CN1893926B (no)
AU (1) AU2004290476A1 (no)
BR (1) BRPI0416650A (no)
CA (1) CA2588012A1 (no)
MX (1) MXPA06005688A (no)
NO (1) NO20062877L (no)
RU (1) RU2369384C2 (no)
WO (1) WO2005048986A1 (no)
ZA (1) ZA200604808B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4599849B2 (ja) * 2004-02-18 2010-12-15 コニカミノルタエムジー株式会社 リポソーム含有製剤の製造方法、およびリポソーム含有製剤
US8772359B2 (en) * 2006-11-08 2014-07-08 Cp Kelco U.S., Inc. Surfactant thickened systems comprising microfibrous cellulose and methods of making same
US9045716B2 (en) 2006-11-08 2015-06-02 Cp Kelco U.S., Inc. Surfactant thickened systems comprising microfibrous cellulose and methods of making same
CN101959503A (zh) 2008-02-29 2011-01-26 财团法人名古屋产业科学研究所 眼后节到达用脂质体和眼后节疾病用医药组合物
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
WO2010077165A1 (en) * 2008-12-31 2010-07-08 Obschestvo S Ogranichennoi Otvetstvennostju Scientific Company Flamena Phospholipid emulsion containing dihydroquercetin, and method of producing thereof
JP6189749B2 (ja) * 2010-06-23 2017-08-30 ブライトサイド イノベーションズ，インコーポレイティド レシチン担体小胞とその作製方法
EP2771341A4 (en) * 2011-10-28 2015-09-23 Univ Texas NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
SG11201404979RA (en) * 2012-02-17 2014-10-30 Celsion Corp Thermosensitive nanoparticle formulations and method of making the same
JPWO2014017233A1 (ja) * 2012-07-27 2016-07-07 住友重機械工業株式会社 微生物用活性調節剤及び微生物の活性を調節する方法
RU2529179C1 (ru) * 2013-04-23 2014-09-27 Общество с ограниченной ответственностью "Уральский центр биофармацевтических технологий" Стабилизатор липосомальных суспензий и способ его получения
CN107750156B (zh) 2015-05-04 2020-08-21 沃桑缇斯股份公司 用于制备跨膜pH梯度囊泡的方法
CN108697681B (zh) * 2016-02-15 2022-01-25 建明(中国)科技有限公司 水溶性亲脂性材料
CN111432801A (zh) * 2017-12-21 2020-07-17 台湾微脂体股份有限公司 缓释型曲普坦组合物及通过皮下或类似途径使用其的方法
US20220249375A1 (en) * 2019-06-28 2022-08-11 Jiangsu Hengrui Medicine Co., Ltd. Sustained-release lipid composition and preparation method therefor
WO2021041374A1 (en) * 2019-08-28 2021-03-04 Cai Gu Huang Liposome formulation of fluticasone furoate and method of preparation
RU2712079C1 (ru) * 2019-09-05 2020-01-24 Федеральное государственное бюджетное учреждение науки "Уральский научно-практический центр радиационной медицины Федерального медико-биологического агентства" (ФГБУН УНПЦ РМ ФМБА России) Липосомальное лекарственное средство для лечения местных радиационных поражений кожи
CN113197848B (zh) * 2021-05-24 2023-06-09 成都欣捷高新技术开发股份有限公司 一种重酒石酸间羟胺药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
WO1990003808A1 (en) * 1988-10-07 1990-04-19 The Liposome Company, Inc. Heat treating liposomes
EP0472639A4 (en) * 1989-05-15 1992-07-01 The Liposome Company, Inc. Accumulation of drugs into liposomes by a proton gradient
JP3383704B2 (ja) * 1993-04-02 2003-03-04 わかもと製薬株式会社 安定なリポソーム水分散液
US5451408A (en) * 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
GB9605915D0 (en) * 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
GB9708066D0 (en) * 1997-04-22 1997-06-11 Woolcombers Group Plc Compositions and their use
AU2003230600B2 (en) * 2002-03-05 2009-06-04 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections

Also Published As

Publication number Publication date
JP2007511545A (ja) 2007-05-10
RU2369384C2 (ru) 2009-10-10
MXPA06005688A (es) 2006-12-14
AU2004290476A1 (en) 2005-06-02
CA2588012A1 (en) 2005-06-02
CN1893926A (zh) 2007-01-10
NO20062877L (no) 2006-08-21
WO2005048986A1 (en) 2005-06-02
KR20060123341A (ko) 2006-12-01
RU2006121554A (ru) 2007-12-27
CN1893926B (zh) 2010-09-08
EP1689364A4 (en) 2008-10-29
CN101889981A (zh) 2010-11-24
US20070269502A1 (en) 2007-11-22
BRPI0416650A (pt) 2007-01-16
EP1689364A1 (en) 2006-08-16

Similar Documents

Publication Publication Date Title
ZA200604808B (en) Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents
IL173808A0 (en) Pharmaceutical liposomal formulations
EP1553956A4 (en) FORMULATION FOR LIPOPHILIC ACTIVE SUBSTANCES
EP1622540A4 (en) FORMULATIONS FOR CELL-PLAN-DEPENDENT CANCER
IL173287A0 (en) Azepine derivatives as pharmaceutical agents
IL176014A0 (en) Azepinoindole derivatives as pharmaceutical agents
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
SI1381346T1 (sl) Farmacevtski sestavki, ki vsebujejo formoterol
IL171941A0 (en) Pharmaceutical compositions containing a benzamide derivative
HK1084338A1 (en) Pharmaceutical formulation comprising lanthanum compounds
EP1712240A4 (en) STABLE MEDICAL WATER BASED PREPARATION WITH ANTIBODY
IL172824A0 (en) Pharmaceutical formulations
HK1183446A1 (en) Stable pharmaceutical composition containing factor viii viii
GB0302671D0 (en) Pharmaceutical formulations
EP1631239A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE COMPOUNDS OF VITAMIN D
HK1084670A1 (en) Pharmaceutical compositions comprising cabbinochreme type compounds
GB0302672D0 (en) Pharmaceutical formulations
GB0316341D0 (en) Pharmaceutical formulations
EP1480649A4 (en) STABLE PHARMACEUTICAL COMPOSITIONS
GB0316889D0 (en) Pharmaceutical agents
IL172304A0 (en) Pharmaceutical compositions comprising active vitamin d compounds
AU2003302320A8 (en) Seterocyclic quinones as pharmaceutical agents
EP1669087A4 (en) PREPARATION CONTAINING A BASIC MEDICINAL PRODUCT
IL174589A0 (en) Pharmaceutical compositions containing tetrahydrobiopterin
GB0316335D0 (en) Pharmaceutical formulations